Overview

  • Product nameCiproxifan maleate
  • Description
    Potent prototypic H3 inverse agonist / antagonist
  • Biological descriptionPotent prototypic H3 inverse agonist / antagonist (pKi = 7.2 nM). Improves attention and wakefulness in vivo. Additionally improves memory function.
  • Purity> 98%

Properties

  • Chemical nameCyclopropyl [4-[3-(1H-imidazol-4-yl)propoxy]phenyl]methanone maleate
  • Molecular weight386.40
  • Chemical structureChemical Structure
  • Molecular formulaC16H18N2O2.C4H4O4
  • CAS Number184025-19-2
  • Storage instructionsStore at +4°C. Store under Desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overviewSoluble in DMSO to 100 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILESO=C(O)/C=C\C(=O)O.O=C(C1CC1)c3ccc(OCCCc2cncn2)cc3
  • Source

    Synthetic

  • Research areas

    References for Ciproxifan maleate (ab120779)

    This product has been referenced in:
    • Bardgett ME  et al. Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease. Neurobiol Learn Mem 95:64-72 (2011). Read more (PubMed: 21073971) »
    • Fox GB  et al. Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization. J Pharmacol Exp Ther 305:897-908 (2003). Read more (PubMed: 12606600) »
    • Ligneau X  et al. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 287:658-66 (1998). Read more (PubMed: 9808693) »
    • Felberg NT  et al. CEA family syndrome. Abnormal carcinoembryonic antigen (CEA) levels in asymptomatic retinoblastoma family members. Cancer 37:1397-402 (1976). Read more (PubMed: 1260660) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120779.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"